Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Times Interest Earned (2018 - 2025)

X4 Pharmaceuticals' Times Interest Earned history spans 8 years, with the latest figure at -$10.84 for Q4 2025.

  • For Q4 2025, Times Interest Earned rose 30.06% year-over-year to -$10.84; the TTM value through Dec 2025 reached -$9.79, down 135.78%, while the annual FY2025 figure was -$9.79, 135.78% down from the prior year.
  • Times Interest Earned reached -$10.84 in Q4 2025 per XFOR's latest filing, up from -$12.19 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $32.68 in Q2 2024 to a low of -$31.41 in Q4 2021.
  • Average Times Interest Earned over 5 years is -$15.81, with a median of -$19.85 recorded in 2022.
  • Peak YoY movement for Times Interest Earned: surged 245.37% in 2024, then tumbled 135.97% in 2025.
  • A 5-year view of Times Interest Earned shows it stood at -$31.41 in 2021, then grew by 28.82% to -$22.36 in 2022, then surged by 40.24% to -$13.36 in 2023, then decreased by 16.02% to -$15.5 in 2024, then skyrocketed by 30.06% to -$10.84 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Times Interest Earned are -$10.84 (Q4 2025), -$12.19 (Q3 2025), and -$11.75 (Q2 2025).